Randomization of endovascular treatment with stent-retriever and/or thromboaspiration versus best medical therapy in acute ischemic stroke due to large vessel occlusion trial: Rationale and design

Article

Abstract: Background: RESILIENT is a prospective, multicenter, randomized phase III trial to test the safety,

Palabras claves:

Acute stroke therapy, developing country, Ischemic stroke, stroke, thrombectomy, Treatment

Autores:

Bezerra D.D.C., Broderick J.P., Dabus G., Freitas G.R.d., Frudit M.E., Giansante Abud D., Haussen D.C., José Mont’Alverne F., Liebeskind D.S., Lima F.O., Martins S.O., Molina C.A., Nogueira R.G., Octavio Marques Pontes-Neto, Oliveira-Filho J., Passos J.E.F., Passos P., S Silva G., Saver J.L., Wagner M.B.

Fuentes:

scopus